Analgesia postcesárea con 10 mg de bupivacaína al 0,5% más 0,15mg de morfina vs 10 mg de bupivacaína al 0,5%, en anestesia subaracnoidea, Hospital Vicente Corral Moscoso, Cuenca 2010

Abstract

Objective. To compare the analgesia posoperatoria and indirect effect produced by 10 mgs of bupivacaína to 0.5% + 150 micrograms of morphine versus 10 mgs of bupivacaína to 0.5%, in subarachnoid anesthesia for Cesarean.

Material and methods. With an experimental design maternal ones programmed for Cesarean were included 150, divided in two equal groups group VM it received 10 mgs of bupivacaína + 150 micrograms of morphine and group B 10 mgs of bupivacaína to 0.5%.

The analgesia in a scale EAV of four dimensions was moderate (without pain, slight pain, moderate pain and severe pain), to 2, 6, 12, 24 and 48 h of the surgery and registered the indirect effect.

Results. During the first 6 hours 94.7% of patients of group VM and 8% of group B, did not have pain (P < 0.0001), but to the 12 and 24 hours the pain was similar in both groups. To the 48 hours P were more patients with slight pain in group VM (= 0.012) although in no of the groups there was moderate nor severe pain.

The nausea incidence was significantly greater in the patients than they received morphine and was prurito in 60% of this group.

Discussion. The results of the work differ from the published ones that report major time of analgesia. The indirect effect were similar to the described ones in Literature.

DeCS: COMPARATIVE STUDY; MORPHINE-THERAPEUTIC USE; BUPIVACAINE- THERAPEUTIC USE; PAIN, POSTOPERATIVE-THERAPY; ANESTHESIA, SPINAL-METHODS